| Introduction I Fernandes, MATM Broekmans, M dos Anjos Ribeiro, I Sims Petrographic Atlas: Characterisation of Aggregates Regarding Potential …, 2016 | 395* | 2016 |
| Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer. JT Coates, S Sun, EE Martin, D McLoughlin, BP Danysh, K Slowik, ... | 74 | 2021 |
| Tumor pH and protein concentration contribute to the signal of amide proton transfer magnetic resonance imaging KJ Ray, MA Simard, JR Larkin, J Coates, P Kinchesh, SC Smart, ... Cancer research 79 (7), 1343-1352, 2019 | 74 | 2019 |
| Radiogenomics and radiotherapy response modeling I El Naqa, SL Kerns, J Coates, Y Luo, C Speers, CML West, ... Physics in Medicine & Biology 62 (16), R179, 2017 | 58 | 2017 |
| Big data analytics for prostate radiotherapy J Coates, L Souhami, I El Naqa Frontiers in oncology 6, 149, 2016 | 51 | 2016 |
| Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer J Coates, AK Jeyaseelan, N Ybarra, M David, S Faria, L Souhami, F Cury, ... Radiotherapy and Oncology 115 (1), 107-113, 2015 | 38 | 2015 |
| Local chemotherapeutic agents for the treatment of ocular malignancies BF Fernandes, K Nikolitch, J Coates, G Novais, A Odashiro, PP Odashiro, ... survey of ophthalmology 59 (1), 97-114, 2014 | 34 | 2014 |
| A guide to outcome modeling in radiotherapy and oncology: listening to the data I El Naqa CRC Press, 2018 | 30 | 2018 |
| Standardization of terminology for episodes of hematopoietic stem cell patient transplant care CF LeMaistre, S Farnia, S Crawford, J McGuirk, RT Maziarz, J Coates, ... Biology of Blood and Marrow Transplantation 19 (6), 851-857, 2013 | 27 | 2013 |
| Targeting tumour hypoxia: shifting focus from oxygen supply to demand JT Coates, M Skwarski, GS Higgins The British Journal of Radiology 92 (1093), 20170843, 2018 | 22 | 2018 |
| Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to sacituzumab govitecan in triple-negative breast cancer. Cancer … JT Coates, S Sun, I Leshchiner, N Thimmiah, EE Martin, D McLoughlin, ... CD-21-0702.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 20 | |
| Genomics models in radiotherapy: From mechanistic to machine learning J Kang, JT Coates, RL Strawderman, BS Rosenstein, SL Kerns Medical physics 47 (5), e203-e217, 2020 | 19 | 2020 |
| Outcome modeling techniques for prostate cancer radiotherapy: Data, models, and validation J Coates, I El Naqa Physica Medica 32 (3), 512-520, 2016 | 16 | 2016 |
| Hypoxia-inducible factor-1α and its role in the proliferation of retinoblastoma cells BF Fernandes, J Coates, AN Odashiro, C Quezada, A Huynh, ... Pathology & Oncology Research 20 (3), 557-563, 2014 | 13 | 2014 |
| Sacituzumab Govitecan, combination with PARP inhibitor, Talazoparib, in metastatic triple-negative breast cancer (TNBC): Translational investigation A Bardia, JT Coates, L Spring, S Sun, D Juric, N Thimmiah, A Niemierko, ... Cancer Research 82 (12_Supplement), 2638-2638, 2022 | 12 | 2022 |
| The anti-malarial drug atovaquone potentiates platinum-mediated cancer cell death by increasing oxidative stress JTT Coates, G Rodriguez-Berriguete, R Puliyadi, T Ashton, R Prevo, ... Cell Death Discovery 6 (1), 110, 2020 | 12 | 2020 |
| Radiomic and radiogenomic modeling for radiotherapy: strategies, pitfalls, and challenges JTT Coates, G Pirovano, I El Naqa Journal of Medical Imaging 8 (3), 031902-031902, 2021 | 11 | 2021 |
| Detrusor after‐contraction on ambulatory urodynamics in symptomatic women R Veeratterapillay, J Coates, A Leonard, R Pickard, M Drinnan, C Harding International Journal of Urology 22 (11), 1058-1062, 2015 | 7 | 2015 |
| Radiogenomics models in precision radiotherapy: from mechanistic to machine learning J Kang, JT Coates, RL Strawderman, BS Rosenstein, SL Kerns arXiv preprint arXiv:1904.09662, 2019 | 3 | 2019 |
| Motivation for the inclusion of genetic risk factors of radiosensitivity alongside dosimetric and clinical parameters in predicting normal tissue effects J Coates Acta Oncologica 54 (8), 1230-1231, 2015 | 3 | 2015 |
Issam El Naqa, PhD, FAAPM, FIEEE, F...Chair of Machine Learning, H. Lee Moffitt Cancer CenterVerified email at moffitt.org
